The effect of flaxseed powder on the treatment of polycystic ovarian syndrome
Phase 3
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT20120704010181N11
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 56
Inclusion Criteria
Patients with polycystic ovarian syndrome
BMI less than 35 kg/m2
Exclusion Criteria
Chronic diseases such as heart disease, diabetes, cancer, Thyroid gland disorders
Following the weight loss program in the last 6 months.
Taking any nutritional supplement
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Testosterone levels. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;SHBG levels. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;Serum levels of insulin. Timepoint: At the beginning and end of the study. Method of measurement: Using ELISA Kit.;Insulin resistance. Timepoint: At the beginning and end of the study. Method of measurement: Using HOMA-IR equation.;Insulin sensitivity. Timepoint: At the beginning and end of the study. Method of measurement: Using QUICKI equation.
- Secondary Outcome Measures
Name Time Method Grade Hirsutism Based on Freeman Galway questionnaire, Score more than 8. Timepoint: At the beginning and end of the study. Method of measurement: Based on Freeman Gallo's Questionnaire.;Menstrual Cycle. Timepoint: At the beginning and end of the study. Method of measurement: Based on individual interviews.